BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3036503)

  • 1. Antibody response to individual cytomegalovirus structural proteins in different groups of subjects.
    Mirolo G; Baldassarri B; Ripalti A; Re MC; Clementi M; Manzin A; Landini MP
    Eur J Clin Microbiol; 1987 Apr; 6(2):207-10. PubMed ID: 3036503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between antibody titres against human cytomegalovirus detected by enzyme immunoassay and titres to individual viral polypeptides studied by immunoblotting.
    Mirolo G; Landini MP; Baldassarri B; Re MC; Lazzarotto T; La Placa M
    Microbiologica; 1986 Jul; 9(3):373-9. PubMed ID: 3018455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
    van Zanten J; van der Giessen M; van Son WJ; The TH
    J Med Virol; 1993 Jan; 39(1):80-7. PubMed ID: 8380844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
    Landini MP; Rossier E; Schmitz H
    J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient.
    Shimokawa K; Murayama T; Ishida S; Furukawa T
    J Med Virol; 1987 Apr; 21(4):339-46. PubMed ID: 3035072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique.
    Porath A; Hanuka N; Keynan A; Sarov I
    J Med Virol; 1987 Jul; 22(3):223-30. PubMed ID: 3040895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.
    Landini MP; Re MC; Mirolo G; Baldassarri B; La Placa M
    J Med Virol; 1985 Dec; 17(4):303-11. PubMed ID: 3001220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of occurrence of antibodies to human cytomegalovirus as demonstrated by immunofluorescence and indirect hemagglutination techniques.
    Michelson S; Cabau N; Boue A; Horodniceanu F
    J Clin Microbiol; 1979 Jan; 9(1):149-51. PubMed ID: 219018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM to human cytomegalovirus: comparison of two enzyme immunoassays and IgM reactivity to viral polypeptides detected by immunoblotting.
    Re MC; Landini MP
    J Clin Lab Anal; 1989; 3(3):169-73. PubMed ID: 2547041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.
    Pereira L; Hoffman M; Cremer N
    Infect Immun; 1982 Jun; 36(3):933-42. PubMed ID: 6284646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection.
    Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Jahn G; Plachter B
    J Clin Microbiol; 1995 Jul; 33(7):1927-30. PubMed ID: 7665674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection.
    Landini MP; Mirolo G; Coppolecchia P; Re MC; La Placa M
    Microbiol Immunol; 1986; 30(7):683-95. PubMed ID: 3022114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis.
    Lazzarotto T; Paya CV; Smith TF; Wiesner RH; Krom R; Landini MP
    Microbiologica; 1992 Jan; 15(1):15-22. PubMed ID: 1313529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and differentiation of cytomegalovirus antibodies by radioimmunoassay.
    Jankowski MA; Gut W; Nawrocka E; Kantoch M
    J Virol Methods; 1980; 1(3):133-8. PubMed ID: 6268645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
    Basson J; Tardy JC; Aymard M
    Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The course of anti-cytomegalovirus antibodies during pregnancy].
    Panà A; Santi AL; Divizia M; Vescia N
    Nuovi Ann Ig Microbiol; 1979; 30(5):321-9. PubMed ID: 233381
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivity of cytomegalovirus structural polypeptides with different subclasses of IgG present in human serum.
    Landini MP; Baldassarri B; Mirolo G; Ripalti A; La Placa M
    J Infect; 1988 Mar; 16(2):163-7. PubMed ID: 2832481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interchangeable ELISA for cytomegalovirus antigen and antibody.
    Sundqvist VA; Wahren B
    J Virol Methods; 1981 Apr; 2(5):301-12. PubMed ID: 6262352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.
    Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH
    Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.